GILD : Analysis & Opinions

  • Showing 1-100 of 134 items
  • 1
  • 2
  • >>
  1. Breaking Down XLV: 3 Components That Are Most Attractive

    May 9, 2016
    Discover three attractive component stocks in the Health Care Select Sector SPDR ETF, and learn which company may be the ...
  2. Gilead Stock: Capital Structure Analysis (GILD)

    May 8, 2016
    Analyze the capital structure of Gilead Sciences to understand the impacts of debt and equity financing. Identify trends ...
  3. Gilead Stock: Analyzing 3 Key Customers (GILD)

    May 5, 2016
    Learn about a handful of important Gilead Sciences customers, including several major pharmaceutical distributors and two ...
  4. Gilead Stock Punished on Q1 Earnings Miss (GILD)

    May 2, 2016
    This was not the quarter investors were gearing up for given the number of price target increases GILD stock enjoyed in the ...
  5. The 3 Largest Alpha-Seeking ETFs (PKW, PDP)

    May 1, 2016
    Learn the tactics of the three largest alpha-seeking ETFs, such as tracking share buybacks and and finding companies with ...
  6. Gilead Stock: Analyzing 5 Key Suppliers (GILD)

    April 29, 2016
    Take a closer look at several key pharmaceutical companies providing Gilead Sciences with important inputs to its pharmaceutical ...
  7. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  8. 3 Expensive All-Cap ETFs Worth Your While (KNOW, PDP)

    April 21, 2016
    Learn why high expense ratios may not matter when it comes to all-cap ETFs, as well as the funds that have outperformed their ...
  9. Gilead to Provide Healthy Dose of Growth (GILD)

    April 18, 2016
    It's always a good sign when earnings and revenue estimates suggest growth and not a decline.
  10. Gilead's Price Target Raised at Jefferies (GILD)

    April 7, 2016
    Even with the stock's recent rise, GILD stock, which has a consensus buy rating with average analyst price target of $115, ...
  11. Gilead Sciences Rise on Hepatitis C Strength (GILD, MRK)

    April 4, 2016
    Gilead's hepatitis C franchise will prove durable in the face of increased competition, analysts believe.
  12. 3 Best Dividend-Paying U.S. Health Care Mutual Funds (VGHCX, ...

    April 2, 2016
    Find out which mutual funds are paying the highest dividend yields in the health care sector, which has underperformed all ...
  13. TRBCX: Portfolio Trends in 2016

    March 25, 2016
    Learn about the portfolio shifts in the T. Rowe Price Blue Chip Growth Fund for 2016 and consider whether the fund is right ...
  14. PRHSX: Portfolio Trends in 2016

    March 23, 2016
    Discover how the T. Rowe Price Health Sciences Fund is positioned in 2016, and learn what trends in the portfolio may help ...
  15. AIVSX: Portfolio Trends in 2016

    March 23, 2016
    Discover the year-over-year portfolio trends in the American Funds Investment Company of America and learn if the 82-year-old ...
  16. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  17. FPURX: Overview of Fidelity Puritan Fund

    March 18, 2016
    Learn about Fidelity Investments' mutual fund offerings, collective long term performance, and read specific analysis of ...
  18. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  19. Has Gilead Sciences Become a Value Stock? (GILD)

    March 18, 2016
    Combined with Gilead's 43-cent per share dividend that yields 1.90% annually, it's tough to not appreciate the attractive ...
  20. (IBB) iShares NASDAQ Biotech SPDR ETF: Top 5 Holdings

    March 16, 2016
    Take a close look at the strong fundamentals underlying the top five holdings of the iShares NASDAQBiotechnology ETF as it ...
  21. Healthcare Sector: Industries Snapshot (XLV, JNJ)

    March 15, 2016
    Discover the six industries that make up the health care sector in the Standard and Poor's 500, and learn which companies ...
  22. How Merck and Daktari Are Working together to Create the HCV ...

    March 12, 2016
    Find out why Merck invested in privately owned Daktari Diagnostics, a company working on a Hepatitis C diagnostics test. ...
  23. 3 Plays for the Biotech Bear Market (GILD, UTHR)

    March 8, 2016
    These short plays should profit from the developing bear market in the biotech sector.
  24. Analyzing Gilead's Return on Equity (GILD, NVO)

    March 7, 2016
    Explore Gilead Science's 2015 return on equity (ROE). Learn about the impact of net margin, asset turnover and financial ...
  25. Gilead's 3 Most Profitable Lines of Business (GILD)

    March 6, 2016
    Discover the top three most profitable products generating over 65% of sales for Gilead Sciences to understand if this stock ...
  26. The 5 Best Performing Stocks in the Last 20 Years (GMCR, CELG)

    February 27, 2016
    Find out which six stocks have performed the best over the past 20 years, which industries generated the most growth and ...
  27. Is Gilead Stock Suitable for Your IRA or Roth IRA? (GLID)

    February 19, 2016
    Learn why Gilead's growing revenues, healthy margins and attractive valuations make it an ideal investment for your traditional ...
  28. 3 Companies With High Working Capital (GT, GILD)

    February 18, 2016
    Learn about working capital, its importance in determining corporate financial stability and three stocks with high working ...
  29. Gilead's 3 Key Financial Ratios (GILD)

    February 13, 2016
    Learn about key financial ratios for Gilead Sciences. Read about a large debt offering the company made in the third quarter ...
  30. Will Gilead's Earnings Be a Shot in the Arm?

    February 1, 2016
    Investors are concerned about the extent to which Gilead's revenue growth, particularly in its hepatitis C business, can ...
  31. Are These the Top Biotech Stocks of 2016?

    January 19, 2016
    These three biotech stocks are likely hold up better than their peers in 2016.
  32. The Top 10 Healthcare Stocks for 2016 (ABT, AGN)

    January 6, 2016
    Learn about the top 10 health care stocks expected to grow in 2016, with brief insights into each company's growth potential ...
  33. The Top 5 Large-Cap Healthcare Stocks for 2016 (GILD, ANTM)

    January 6, 2016
    Learn about the potential direction for large-cap stocks in the health care sector in 2016, drug pricing headwinds and the ...
  34. The Top 10 Large Cap Stocks for 2016 (BCS, AAPL)

    January 5, 2016
    Discover the top 10 large-cap stocks that are expected to grow in 2016, with summaries and individual growth outlooks for ...
  35. The Top 4 Dividend Paying Biotechnology Stocks for 2016 (AMGN, ...

    January 5, 2016
    Discover the top four dividend-bearing biotech stocks for 2016, including one undervalued stock trading at bargain-basement ...
  36. The Top 5 Large Cap Biotechnology Stocks for 2016 (AMGN, BIIB)

    January 5, 2016
    Discover the top five biotechnology stocks for 2016. Learn each company's main revenue drivers and what factors cause their ...
  37. Top 3 NASDAQ-Listed Stocks for 2016 (AAPL, GILD)

    December 23, 2015
    Learn about the top stocks listed on the NASDAQ for 2016. See how Netflix stock has risen dramatically in 2015 and could ...
  38. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  39. 8 Blue Chip Stocks with Low P/E Ratios

    December 1, 2015
    Discover why the price/earnings (P/E) ratio is important in determining the relative value of a stock and find out which ...
  40. 4 Reasons Gilead Sciences Should be in Your Stock Portfolio (GILD)

    November 30, 2015
    Discover how Gilead Sciences fits into most investment portfolios and learn about the company's drug pipeline and future ...
  41. Gilead Sciences Stock: A Dividend Analysis (GILD)

    October 28, 2015
    Discover analysis of the dividend policy of Gilead Sciences, Inc., and learn about its historical earnings growth and the ...
  42. High Hopes For Apple, Alibaba, Other Earnings This Week

    October 25, 2015
    It will be a busy week on the earnings front, with many blue chip companies reporting. Results from Apple are among the ...
  43. FDA's Warning Shakes Up Hep C Landscape

    October 23, 2015
    Yesterday, the FDA issued a warning highlighting the risk of potential serious liver injury with Viekira Pak, a drug used ...
  44. The Biggest Risks of Investing in Gilead Stock (GILD)

    September 30, 2015
    Examine the current position of Gilead Sciences, Inc., and learn the major risks for investors considering buying Gilead ...
  45. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    August 27, 2015
    Between the July 31 and August 14 settlement dates, the number of shares short in the leading biotech and emerging pharmaceutical ...
  46. Key Financial Ratios to Analyze Biotech Companies (AMGN, GILD)

    August 20, 2015
    Explore the rapidly growing biotechnology industry, and learn some of the key financial ratios investors use to analyze companies ...
  47. Top 3 Biotech ETFs (XBI, IBB)

    August 14, 2015
    Learn about three popular ETFs in the biotechnology sector, how they differ, and which ones may be appropriate for long term ...
  48. 3 Value Stocks Millennials Should Consider (COF, GILD)

    August 14, 2015
    Understand what a value stock is and why a value stock would be attractive to a millennial. Learn about three value stocks ...
  49. Celgene Vs. Gilead: Vetting for the Best Biopharma

    August 14, 2015
    Read about the similarities between the drug companies Celgene and Gilead, and learn about promising potential drug candidates ...
  50. 3 Stocks to Protect Your Portfolio From Inflation (CLX, GILD)

    August 13, 2015
    Discover three stocks to protect portfolios against inflation. The best companies to protect against inflation are those ...
  51. How to Create a Personal Risk Management Plan

    July 10, 2015
    Investors should consider these strategies to establish a risk management plan.
  52. What Is the Pharmacy Benefit Management Industry?

    July 2, 2015
    PBMs, acting as third party administrators and negotiators, are essential to facilitating transactions between the moving ...
  53. Could This Patent Decision Be Trouble for Gilead? (GILD)

    June 24, 2015
    When it comes to treating hepatitis C, Gilead Sciences (NASDAQ: GILD) has become a veritable monster. Four years ago, the ...
  54. Are These 3 Biotech Stocks Dirt Cheap? (ABBV, AMAG)

    June 22, 2015
    Everyone loves a bargain, and investors like me are no exception. That's why I like to check in with stocks every quarter ...
  55. Better Dividend Stock: Amgen or Gilead Sciences? (AMGN, GILD)

    June 19, 2015
    Dividend investors don't have very many investing options in the high-flying biotechnology industry, but of those choices, Amgen ...
  56. Why Insider Selling Is a Bad Reason to Sell Gilead (GILD)

    June 15, 2015
    Biotech blue chip stock Gilead Sciences (NASDAQ: GILD) has been nothing short of unstoppable over the past four years. Over ...
  57. Gilead Sciences' Under-the-Radar Growth Machine (GILD)

    June 10, 2015
    It's truly amazing just how quickly Gilead Sciences (NASDAQ: GILD) transformed itself from just another somewhat large biotechnology ...
  58. 10 Developments By Gilead Sciences That Could Boost Profits (GILD)

    June 3, 2015
    Learn about 10 drugs in the pipeline for Gilead Sciences, and learn how it has acquired smaller companies with promising ...
  59. Is It Too Late To Invest In Gilead Sciences? (GILD)

    June 2, 2015
    Discover whether it is too late to invest in Gilead Sciences. Gilead is a leading biotechnology company with treatments for ...
  60. Merck Takes Aim at Gilead. Should You Worry? (GILD, MRK)

    May 29, 2015
    The battle for hepatitis C dominance is about to get even more interesting for investors over the coming year. That's because ...
  61. Will Gilead's Hepatitis C Dominance Collapse? (GILD, JNJ)

    May 28, 2015
    The launch of two multibillion-dollar blockbuster HCV drugs in the past year and a half has firmly established Gilead Sciences (NASDAQ: ...
  62. Should This Figure Worry Gilead Shareholders? (GILD)

    May 26, 2015
    When it comes to the model biotech company, Gilead Sciences (NASDAQ: GILD) pretty much fits the mold. Gilead has been able ...
  63. Will This Drug Beat Gilead to Market in NASH? (GILD, ICPT)

    May 22, 2015
    A race of sorts is on between Gilead Sciences (NASDAQ: GILD) and Intercept Pharmaceuticals (NASDAQ: ICPT). In a bid to be ...
  64. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  65. Soaring Cash Makes Gilead Cheaper Than You Think (GILD)

    May 20, 2015
    There are a lot of reasons investors may be considering owning shares in Gilead Sciences (NASDAQ: GILD), including the fact ...
  66. 5 Things Gilead Sciences Wants You to Know (GILD)

    May 18, 2015
    It's been a few weeks since Gilead Sciences (NASDAQ: GILD) reported its first-quarter earnings results, but the "wow" factor ...
  67. The Most Important Number for Gilead Shareholders (GILD, ABBV)

    May 12, 2015
    It's been nearly two weeks since biotech blue chip stock Gilead Sciences (NASDAQ: GILD) reported its first-quarter earnings ...
  68. Gilead's Price Cuts Cause Hep C Scripts to Soar (GILD)

    May 5, 2015
    Gilead Sciences (NASDAQ: GILD) didn't make many friends last year when it priced its next-generation hepatitis C drugs, ...
  69. Are These the Top 3 Value Stocks of 2015?

    May 4, 2015
    A look at three value plays for the long-term investor.
  70. Gilead Earnings Preview: What You Should Know (GILD, ABBV)

    April 22, 2015
    Perhaps no biotechnology stock has shaped what it means to improve patient quality of care more in recent years than Gilead ...
  71. Ignore These Risks to Gilead at Your Peril (GILD)

    April 20, 2015
    Gilead Sciences (NASDAQ: GILD) has enjoyed remarkable success in the past year thanks to the launch of two instant billion-dollar ...
  72. How Gilead Plans to Keep Competitors in Check (GILD, ABBV)

    April 14, 2015
    Gilead Sciences (NASDAQ: GILD) has plenty of experience in outmaneuvering competitors. After all, despite competitors' launching ...
  73. Why Merck's Victory Is of Little Concern to Gilead (GILD, MRK)

    April 10, 2015
    Merck (NYSE: MRK) investors can be proud, as the company's persistence appears to be paying off. While Gilead Sciences (NASDAQ: ...
  74. Gilead's Little Tweak Could Produce Big Revenue (GILD, JNJ)

    April 8, 2015
    Sometimes it's the little things companies do that can have the biggest impacts on their bottom line. Take Gilead Sciences ...
  75. Top 7 Roth IRA Stocks for 2015

    April 8, 2015
    Looking for stocks with long-term potential for your Roth IRA? Here are the top seven picks for 2015.
  76. Risks and Rewards of Biotech Companies

    April 1, 2015
    We look at the risks and rewards of investing in biotech companies.
  77. 3 Under-the-Radar Risks for Gilead Sciences (GILD, ACHN)

    March 27, 2015
    Put mildly, biotechnology company Gilead Sciences (NASDAQ: GILD) is nothing short of a cash flow behemoth. Over the past ...
  78. Read This Before You Sell Gilead Sciences (GILD, ABBV)

    March 25, 2015
    Earlier this week, Gilead Sciences (NASDAQ: GILD) reported that nine people who were taking a specific heart disease drug ...
  79. Why These Could Be 2015's 10 Best Biotech Stocks

    March 25, 2015
    A quick look at a 10 biotech companies that are poised to deliver for shareholders in 2015.
  80. Could Gilead's Dividend Have Additional Upside? (GILD)

    March 23, 2015
    Gilead Sciences (NASDAQ: GILD) could offer a blueprint for a successful biotech company for its peers to emulate. The past ...
  81. Gilead Sciences' Drugs: Worth $136 Billion? (GILD)

    March 19, 2015
    Doctors and patients are cheering new advances in treating hepatitis C, a common disease that affects millions of people ...
  82. This Policy Shift Is Big News for Gilead Sciences (GILD)

    March 17, 2015
    GILD data by YCharts. By and large, Gilead Sciences had a banner year in 2014. In December 2013 Gilead witnessed its revolutionary ...
  83. Why Celgene Won't Pay A Dividend Anytime Soon

    March 12, 2015
    The biotech sector has been virtually unstoppable over the past three years and has widely outperformed the broader market. ...
  84. Gilead Sciences: The New Market-Share Leader

    March 2, 2015
    Gilead Sciences's track record of developing and commercializing therapies has turned it into the market-share leader; investros ...
  85. How Gilead Sales Have Grown Conspicuously?

    February 23, 2015
    Learn how Gilead sales have climbed from $1.33 billion in 2004 to $24.89 billion as of the end of 2014.
  86. Day's First Trade Can Serve As Support/Resistance

    January 22, 2015
    The first trade of the day in liquid markets defines a narrow price level that can act as support or resistance for the entire ...
  87. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  88. How Does Janus's Fund Lineup Look Now?

    November 14, 2014
    With the addition of 'Bond King' Bill Gross, Janus is a changed firm. Here's what its fund lineup looks like now.
  89. Big Swings in Biotech Short Interest

    October 13, 2014
  90. Shocking Prediction #9: 'Nightmare Pandemics' Could Make These ...

    August 27, 2014
    Let me start off today's issue with a warning... We're not trying to sound alarmist. It does absolutely zero good ...
  91. 4 Large-Cap Healthcare Stocks To Watch

    August 18, 2014
    Healthcare continues to a be a hot sector. Here are four pharma stocks to keep an eye on for entry points.
  92. How Gilead Sciences Became A Big Name In Biotech

    August 11, 2014
    How does a company start with an unfortunate bout of dengue fever and grow to be a multibillion dollar corporation?
  93. The Most Undervalued Stock In The Biotech Universe

    May 6, 2014
    If you've been paying attention to the biotech and pharmaceutical space over the past few months (like my colleague David ...
  94. Four Reasons I Love Monthly Dividend Payers... And You Should, ...

    May 6, 2014
    Recently, I investigated installing solar panels on my roof to reduce my monthly energy bills. The financial calculations ...
  95. What Are The Best Bets In Biotech?

    May 2, 2014
    The NASDAQ Biotechnology Index is off nearly 20% as its components busy themselves with hostile bids and frenzied buying ...
  96. 7 Picks For A Sector That's Heating Up

    April 29, 2014
    We're right in the middle of earnings season, which means that most mid- and large-cap companies have reported results, with ...
  97. This Sector's Earnings Are Just Heating Up

    April 29, 2014
    We're right in the middle of earnings season, which means that most mid- and large-cap companies have reported results, with ...
  98. Markets Falling? Get Your Defense Ready

    April 14, 2014
    The stock market is getting whacked. The question now for many investors is, what to do about it. The first thing to ...
  99. Stocks Looking to Bounce off Trendline Support

    March 12, 2014
    These stocks are testing trendline support, offering a buying opportunity. If they fall further though, it warns of a correction.
  100. The 3 Best Growth Stocks To Buy On A Pullback

    February 13, 2014
    Nothing feels worse for investors than missing the boat, and I'm sure there's plenty of regret to go around these ...
  • Showing 1-100 of 134 items
  • 1
  • 2
  • >>
Trading Center